GvHD prophylaxis with KRP203, a sphingosine-1-phosphate receptor modulator, is safe and may have the potential to improve survival in patients undergoing allogeneic stem cell transplantation https://priothera.com/gvhd-prophylaxis-with-krp203-a-sphingosine-1-phosphate-receptor-modulator-is-safe-and-may-have-the-potential-to-improve-survival-in-patients-undergoing-allogeneic-stem-cell-transplantation/
The role of S1P receptor-1 agonism in thymus-dependent T cell regeneration and graft-versus-tumor activity following experimental allogeneic hematopoietic cell transplantation https://priothera.com/the-role-of-s1p-receptor-1-agonism-in-thymus-dependent-t-cell-regeneration-and-graft-vs-tumor-activity-following-experimental-allogeneic-hematopoietic-cell-transplantation/
The role of S1P receptor-1 agonism in thymus-dependent generation of autoreactive T cells during experimental acute graft-versus-host disease https://priothera.com/the-role-of-s1p-receptor-1-agonism-in-thymus-dependent-generation-of-autoreactive-t-cells-during-experimental-acute-graft-vs-host-disease/
Sphingosine 1-phosphate signaling and its pharmacological modulation in allogeneic hematopoietic stem cell transplantation https://priothera.com/sphingosine-1-phosphate-signaling-and-its-pharmacological-modulation-in-allogeneic-hematopoietic-stem-cell-transplantation/
S1P signaling: new therapies and opportunities https://priothera.com/s1p-signaling-new-therapies-and-opportunities/
Recent Comments